Immunotherapy drug shows promise for Hard-to-Treat brain tumors
Disease control
Completed
This study tested the drug nivolumab in 35 adults with a type of brain tumor (glioma) that has an IDH mutation and came back after previous treatment. The goal was to see if the drug could shrink the tumors. Nivolumab is an immunotherapy that helps the immune system fight cancer,…
Phase: PHASE2 • Sponsor: Fabio Iwamoto, MD • Aim: Disease control
Last updated May 15, 2026 11:56 UTC